New drug trial targets uncontrollable hunger in rare genetic disorder
Disease control
Not yet recruiting
This early-stage study is testing an investigational drug called CSTI-500 in people with Prader-Willi syndrome, a rare genetic disorder that causes constant hunger and behavioral challenges. The main goals are to check if the drug is safe and to find the right dose for each perso…
Phase: PHASE2 • Sponsor: ConSynance Therapeutics • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC